Form 4 for CRL Charles River Laboratories
Accepted 2025-05-05 00:00:00 ET · period of report 2025-05-02 · accession 0001127602-25-013391 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-05 | 2025-05-02 | CRL | Pease Flavia | CFO, Corp. Executive VP | F - Tax | $116.89 | -889 | 10.7K | -8% | -$103.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-02 | F | D | 889 | $116.89 | 10,661 | D | — | — |